GAPDH and Alzheimer disease: The analysis of the PPI network provided valuable insights into the therapeutic potential of the major active components of the PC formula and identified several core targets that are significantly involved in AD, including APP, GAPDH, CASP3, PTGS2, GSK3B, and PPARG.